5454-82-0

Basic information

• Product Name: Cyclobutylmethylamine hydrochloride
• Synonyms: Cyclobutylmethylamine hydrochloride;CyclobutaneMethanaMine hydrochloride;CyclobutaneMethanaMine, hydrochloride (1:1);(AMinoMethyl)cyclobutane hydrochloride;1-CyclobutylMethylaMine hydrochloride;CyclobutaneMethanaMine HCl;CyclobutylMethylaMine, HCl;(aMinoMethyl)cyclobutane hcl
• CAS NO: 5454-82-0
• Molecular Formula: C₅H₁₁N*ClH
• Molecular Weight: 121.60848
• Mol File: 5454-82-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 90.6 °C at 760 mmHg
• Flash Point: 2.1 °C
• Appearance: /
• Density: 0.889 g/cm³
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: DMSO (Slightly), Methanol (Slightly), Water (Slightly)
• Stability: Hygroscopic
• CAS DataBase Reference: Cyclobutylmethylamine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutylmethylamine hydrochloride(5454-82-0)
• EPA Substance Registry System: Cyclobutylmethylamine hydrochloride(5454-82-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 5454-82-0(Hazardous Substances Data)

Usage

Chemical Properties

White solid

Upstream product

• 4426-11-3 cyclobutanecarbonitrile 

Downstream Products

• 1613459-68-9 2-cyclobutyl-6-(diethoxymethyl)-3-fluoro-N-tritylpyridin-4-amine 
• 1582778-48-0 4-(((cyclobutylmethyl)amino)methyl)-3-fluorophenol 
• 1120-56-5 methylidenecyclobutane 
• 96-41-3 Cyclopentanol 
• 4415-82-1 cyclobutanemethanol 
• 142-29-0 cyclopentene 
• 666263-13-4 2-(2-fluoro-3-trifluoromethyl-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-amide 
• 666263-14-5 2-(2-methyl-4-chloro-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-amide 
• 666262-45-9 2-(3-chloro-phenylamino)-4-trifluoromethyl-pyrimidine-5-carboxylic acid cyclobutylmethyl-methyl-amide 

Relevant articles and documents

AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, formula (I) wherein R1. X, m. R2, Y, R3, Z, n, R4. A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

BENZIMIDAZOLE ANTIVIRAL AGENTS

Provided are compounds of Formula (I) and (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such